Zion Market Research has published a new report titled “Drug Discovery Informatics Market by Mode (Outsourced Informatics and In-House Informatics), by Services (Docking and Modular Modeling): Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021.” According to the report, global demand for drug discovery informatics was valued at USD 1.80 billion in 2014 is expected to reach USD 4.70 billion in 2020 and is anticipated to grow at a CAGR of 17.2% between 2015 and 2020.
Get sample report visit at https://www.zionmarketresearch.com/sample/drug-discovery-informatics-market
Drug discovery is a havoc process that requires much time to invent the drug for any disease or disorder. During the invention procedure, it generates the huge amount of data which can be further utilized while clinical study or other during other invention. This data can be stored manipulate and retrieve through the drug discovery analytics.
Drug discovery analytics is a special kind of application or software which can be stores and retrieves the structured and unstructured data that is generated while drug discovery process. The drug discovery analytics helps to reduce the cost of treatment and it provides efficient and accurate data. This kind of data is utilized further by R&D, pharmaceutical, biotech companies and physicians.
Request for Customization Report @ https://www.zionmarketresearch.com/custom/40
The drug discovery informatics market is primarily driven by rising demand for computational technology in the medical industry. Use of computational technology offers the fastest and accurate data to the end-users. However, critical attributes of data evaluation in drug discovery informatics is a major restraint that is likely to impede the growth of the market. Nonetheless, adoption of computational technology in emerging economies is expected to open new opportunities for market participants in near future.
Based on mode, the global drug discovery informatics market is segmented into outsourced informatics and in-house informatics. Among two, in-house informatics was leading mode segment. It accounted more than 50.0% share of the overall revenue generated by global drug discovery informatics market in 2015. Moreover, the outsourced informatics is expected to have significant growth during the years to come.
Know more before buying this report @ https://www.zionmarketresearch.com/inquiry/drug-discovery-informatics-market
Docking, modular modeling, and others are the key services of global drug discovery informatics market. Modular modeling was the foremost service segment that accounted for over 22.0% share of the entire market in 2015. Furthermore, it also expected to grow at a moderate pace due to growing adoption of analytics in the medical industry across the globe.
With the largest share, North America was the dominating regional market for drug discovery informatics in 2015. Asia Pacific is foreseen as a fastest growing region for drug discovery informatics market due to emerging pharmaceutical industries coupled with rising prevalence of cancer disease in China and India. Furthermore, Europe is likely to witness a moderate growth within the forecast period.
Browse detail report with in-depth TOC @ https://www.zionmarketresearch.com/report/drug-discovery-informatics-market
Some of the key players involved in global drug discovery informatics market include ChemAxon, GVK Biosciences, Jubilant Biosys, Selvita, Certara, Infosys, Albany Molecular Research Inc., Boehringer Ingelheim GmBh, DiscoverX, Charles River Laboratories, Covance, Collaborative Drug Discovery Inc., Novo Informatics, UCB, Evotec among others.